Are antiresorptive drugs effective against fractures in patients with diabetes?

Calcified Tissue International

Volumn 88, Issue 3, 2011, Pages 209-214

  Vestergaard, Peter ^a   Rejnmark, Lars ^a   Mosekilde, Leif ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bisphosphonates; Diabetes; Osteoporosis: fractures; Osteoporosis: secondary drug induced; Osteoporosis: therapy; SERMs

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CLODRONIC ACID; CORTICOSTEROID; ETIDRONIC ACID; IBANDRONIC ACID; PAMIDRONIC ACID; RALOXIFENE; RISEDRONIC ACID; STRONTIUM; VITAMIN D; ZOLEDRONIC ACID;

ADULT; AGED; ALCOHOLISM; ARTICLE; BONE TURNOVER; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; FOREARM FRACTURE; FRACTURE; HIGH RISK PATIENT; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; PRIORITY JOURNAL; SPINE FRACTURE; THERAPY EFFECT; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; CASE-CONTROL STUDIES; DENMARK; DIABETES COMPLICATIONS; FEMALE; FRACTURES, BONE; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79954420698     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-010-9450-4     Document Type: Article

References (28)

1. P Vestergaard 2007 Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis Osteoporos Int 18 427 444 17068657 10.1007/s00198-006-0253-4 1:STN:280:DC%2BD2s7jtVCltw%3D%3D (Pubitemid 46354916)
2. M Janghorbani R van Dam W Willett F Hu 2007 Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture Am J Epidemiol 166 495 505 17575306 10.1093/aje/kwm106 (Pubitemid 47283633)
3. N Follak I Kl"ting E Wolf H Merk 2004 Improving metabolic control reverses the histomorphometric and biomechanical abnormalities of an experimentally induced bone deficit in spontaneously diabetic rats Calcif Tissue Int 74 551 560 15354863 10.1007/s00223-003-0069-6 1:CAS:528: DC%2BD2cXks1Kmtr0%3D (Pubitemid 38780291)
4. L Achemlal S Tellal F Rkiouak A Nouijai A Bezza EM Derouiche D Ghafir A El Maghraoui 2005 Bone metabolism in male patients with type 2 diabetes Clin Rheumatol 24 493 496 15747054 10.1007/s10067-004-1070-9 (Pubitemid 43055041)
5. R Bouillon 1992 Diabetic bone disease. Low turnover osteoporosis related to decreased IGF-I production Verh K Acad Geneeskd Belg 54 365 392 1466160 1:STN:280:DyaK3s7gt1Kgtw%3D%3D
6. Z Berberoglu A Gursoy N bayraktar A Yazici N Tutuncu N Demirag 2007 Rosiglitazone decreases serum bone specific alkaline phosphatase activity in postmenopausal diabetic women J Clin Endocrinol Metab 92 3523 3530 17595249 10.1210/jc.2007-0431 1:CAS:528:DC%2BD2sXhtVGqsrnJ (Pubitemid 47435330)
7. JM Kindblom C Ohlsson O Ljunggren MK Karlsson A Tivesten U Smith D Mellström 2009 Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men J Bone Miner Res 24 867 874 10.1359/jbmr.081234
8. O Akin K Gol M Akturk S Erkaya 2003 Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements Gynecol Endocrinol 17 19 29 12724015 1:CAS:528:DC%2BD3sXjt1yrsrw%3D (Pubitemid 36349878)
9. P Gerdhem A Isaksson K Akesson K Obrant 2005 Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus Osteoporos Int 16 1506 1512 15824889 10.1007/s00198-005-1877-5 1:STN:280:DC%2BD2MnnsVCntg%3D%3D (Pubitemid 41790853)
10. N Lee H Sowa E Hinoi M Ferron J Ahn C Confavreux R Dacquin P Mee M McKee D Jung Z Zhang J Kim F Mauvais-Jarvis P Ducy G Karsenty 2007 Endocrine regulation of energy metabolism by the skeleton Cell 130 456 469 17693256 10.1016/j.cell.2007.05.047 1:CAS:528:DC%2BD2sXptlyntbs%3D (Pubitemid 47208519)
11. J Clowes H Allen D Prentis R Eastell A Blumsohn 2003 Octreotide abolishes the acute decrease in bone turnover in response to oral glucose J Clin Endocrinol Metab 88 4867 4873 14557467 10.1210/jc.2002-021447 1:CAS:528:DC%2BD3sXoslemtbc%3D (Pubitemid 37357537)
12. D Black S Greenspan K Ensrud L Palermo J McGowan T Lang P Garnero M Bouxsein J Bilezikian C Rosen 2003 The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis N Engl J Med 349 1207 1215 14500804 10.1056/NEJMoa031975 1:CAS:528:DC%2BD3sXns1Kmsrw%3D (Pubitemid 37152030)
13. S Bonnick K Saag D Kiel M McClung M Hochberg S Burnett A Sebba R Kagan E Chen D Thompson A de Papp 2006 Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years J Clin Endocrinol Metab 91 2631 2637 16636120 10.1210/jc.2005-2602 1:CAS:528: DC%2BD28XntFWgtL4%3D (Pubitemid 44024629)
14. E Lufkin M Whitaker T Nickelsen R Argueta R Caplan R Knickerbocker B Riggs 1998 Treatment of established postmenopausal osteoporosis with raloxifene: a randomized trial J Bone Miner Res 13 1747 1754 9797484 10.1359/jbmr.1998.13. 11.1747 1:CAS:528:DyaK1cXntFOhtLw%3D (Pubitemid 28492005)
15. T Mashiba CH Turner T Hirano MR Forwood DS Jacob CC Johnston DB Burr 2001 Effects of high-dose etidronate treatment on microdamage accumulation and biomechanical properties in beagle bone before occurrence of spontaneous fractures Bone 29 271 278 11557372 10.1016/S8756-3282(01)00575-0 1:CAS:528:DC%2BD3MXms12ktrk%3D (Pubitemid 32823571)
16. BA Lenart DG Lorich JM Lane 2008 Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate N Engl J Med 358 1304 1306 18354114 10.1056/NEJMc0707493 1:CAS:528:DC%2BD1cXjvVarsb8%3D (Pubitemid 351439247)
17. BA Lenart AS Neviaser S Lyman CC Chang F Edobor-Osula B Steele MCH van der Meulen DG Lorich JM Lane 2009 Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study Osteoporos Int 20 1353 1362 19066707 10.1007/s00198-008-0805-x 1:CAS:528:DC%2BD1MXotlyhurY%3D
18. S Dagdelen D Sener M Bayraktar 2007 Influence of type 2 diabetes mellitus on bone mineral density response to bisphosphonates in late postmenopausal osteoporosis Adv Ther 24 1314 1320 18165214 10.1007/BF02877778 1:CAS:528:DC%2BD1cXitlGks7k%3D (Pubitemid 351612237)
19. THM Keegan AV Schwartz DC Bauer DE Sellmeyer JL Kelsey 2004 Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial Diabetes Care 27 1547 1553 15220226 10.2337/diacare.27.7.1547 1:CAS:528:DC%2BD2cXmt1Cmt74%3D (Pubitemid 38857424)
20. T Andersen M Madsen J Jørgensen L Mellemkjær J Olsen 1999 The Danish National Hospital Register Dan Med Bull 46 263 268 10421985 1:STN:280:DyaK1MzltVyrtw%3D%3D
21. J Mosbech J Jørgensen M Madsen K Rostgaard K Thornberg T Poulsen 1995 The Danish National Patient Register: evaluation of data quality [in Danish] Ugeskr Laeger 157 3741 3745 7631448 1:STN:280:DyaK2Mzlsl2msA%3D%3D
22. LE Lévesque JA Hanley A Kezouh S Suissa 2010 Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes BMJ 340 b5087 20228141 10.1136/bmj.b5087
23. D Black S Cummings D Karpf J Cauley D Thompson M Nevitt D Bauer H Genant W Haskell R Marcus S Ott J Torner S Quandt T Reiss K Ensrud 1996 Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures Lancet 348 1535 1541 8950879 10.1016/S0140-6736(96)07088-2 1:CAS:528:DyaK2sXisFCktQ%3D%3D (Pubitemid 26411651)
24. MA Abbassy I Watari K Soma 2010 The effect of diabetes mellitus on rat mandibular bone formation and microarchitecture Eur J Oral Sci 118 364 369 20662909 10.1111/j.1600-0722.2010.00739.x
25. Y Hamada S Kitazawa R Kitazawa H Fujii M Kasuga M Fukagawa 2007 Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress Bone 40 1408 1414 17251074 10.1016/j.bone.2006.12.057 1:CAS:528:DC%2BD2sXktF2ns7c%3D (Pubitemid 46550975)
26. M Ferron E Hinoi G Karsenty P Ducy 2008 Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice Proc Natl Acad Sci USA 105 5266 5270 18362359 10.1073/pnas.0711119105 1:CAS:528:DC%2BD1cXksVOns7Y%3D (Pubitemid 351738545)
27. H Fujii Y Hamada M Fukagawa 2008 Bone formation in spontaneously diabetic Torii-newly established model of non-obese type 2 diabetes rats Bone 42 372 379 18037364 10.1016/j.bone.2007.10.007 1:CAS:528:DC%2BD1cXls1enug%3D%3D
28. P McNair S Madsbad M Christensen C Christiansen O Faber C Binder I Transbøl 1979 Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis Acta Endocrinol 90 463 472 425786 1:STN:280: DyaE1M7ktFyiuw%3D%3D (Pubitemid 9141960)